We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese Rulemaking Escalates Crackdown on Pharma Corruption
Chinese Rulemaking Escalates Crackdown on Pharma Corruption
A drugmaker convicted of bribery in China will have its products barred from being purchased by private and government-funded organizations for two years in the province where it is convicted. A second offense within five years will result in a two-year, nationwide ban.